κ-Opioid receptor agonist protects against ischemic reduction of 2-deoxyglucose uptake in morphine-tolerant rats

Shigenobu Shibata, Keiko Tominaga, Shigenori Watanabe

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

We examined the effects of μ-opioid receptor agonist and antagonists, and κ-opioid receptor agonist on the hypoxia/hypoglycemia-induced reduction in 2-deoxyglucose uptake of rat hippocampal slices. Naloxone, a μ-opioid receptor antagonist and (5,7,8)-(+)-3,4-dichloro-N-methyl-N-(7,8,1-pyrrolidinyl)-1-oxaspirol 4,5 dec-8-yl)-benzeneacetamide methanesulfonate, U-62,066E, a κ-opioid receptor agonist, showed neuroprotective actions against the hypoxia/hypoglycemia-induced deficit in glucose uptake. In contrast, morphine exhibited an exacerbating action. These results suggest that blockade of μ-opioid receptor-and stimulation of κ-opioid receptor-mediated functions has a protective role against the hypoxia/hypoglycemia-induced decreases in glucose metabolism in hippocampal slices. Chronic administration of morphine (10 mg/kg) for 9 days affected neither the basal nor the hypoxia/hypoglycemia-induced reduction in 2-deoxyglucose uptake. Rats treated with morphine chronically exhibited not only tolerance to the analgesic effect but also tolerance to the exacerbating action. However, chronic morphine did not modify U-62,066E-induced neuroprotection. These findings indicate that the receptor mechanisms of neuroprotection produced by the activation of κ-opioid receptors may not be involved in μ-opioid receptor function.

Original languageEnglish
Pages (from-to)197-202
Number of pages6
JournalEuropean Journal of Pharmacology
Volume279
Issue number2-3
DOIs
Publication statusPublished - 1995 Jun 12
Externally publishedYes

Fingerprint

Deoxyglucose
Opioid Receptors
Morphine
Hypoglycemia
Narcotic Antagonists
Benzeneacetamides
Glucose
Naloxone
Analgesics
Hypoxia

Keywords

  • 2-Deoxyglucose
  • Hippocampal slice
  • Ischemia
  • Morphine
  • Tolerance
  • κ-Opioid receptor

ASJC Scopus subject areas

  • Pharmacology
  • Cellular and Molecular Neuroscience

Cite this

κ-Opioid receptor agonist protects against ischemic reduction of 2-deoxyglucose uptake in morphine-tolerant rats. / Shibata, Shigenobu; Tominaga, Keiko; Watanabe, Shigenori.

In: European Journal of Pharmacology, Vol. 279, No. 2-3, 12.06.1995, p. 197-202.

Research output: Contribution to journalArticle

@article{b717dfdd5ce2474795c4da43409cb701,
title = "κ-Opioid receptor agonist protects against ischemic reduction of 2-deoxyglucose uptake in morphine-tolerant rats",
abstract = "We examined the effects of μ-opioid receptor agonist and antagonists, and κ-opioid receptor agonist on the hypoxia/hypoglycemia-induced reduction in 2-deoxyglucose uptake of rat hippocampal slices. Naloxone, a μ-opioid receptor antagonist and (5,7,8)-(+)-3,4-dichloro-N-methyl-N-(7,8,1-pyrrolidinyl)-1-oxaspirol 4,5 dec-8-yl)-benzeneacetamide methanesulfonate, U-62,066E, a κ-opioid receptor agonist, showed neuroprotective actions against the hypoxia/hypoglycemia-induced deficit in glucose uptake. In contrast, morphine exhibited an exacerbating action. These results suggest that blockade of μ-opioid receptor-and stimulation of κ-opioid receptor-mediated functions has a protective role against the hypoxia/hypoglycemia-induced decreases in glucose metabolism in hippocampal slices. Chronic administration of morphine (10 mg/kg) for 9 days affected neither the basal nor the hypoxia/hypoglycemia-induced reduction in 2-deoxyglucose uptake. Rats treated with morphine chronically exhibited not only tolerance to the analgesic effect but also tolerance to the exacerbating action. However, chronic morphine did not modify U-62,066E-induced neuroprotection. These findings indicate that the receptor mechanisms of neuroprotection produced by the activation of κ-opioid receptors may not be involved in μ-opioid receptor function.",
keywords = "2-Deoxyglucose, Hippocampal slice, Ischemia, Morphine, Tolerance, κ-Opioid receptor",
author = "Shigenobu Shibata and Keiko Tominaga and Shigenori Watanabe",
year = "1995",
month = "6",
day = "12",
doi = "10.1016/0014-2999(95)00152-B",
language = "English",
volume = "279",
pages = "197--202",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "2-3",

}

TY - JOUR

T1 - κ-Opioid receptor agonist protects against ischemic reduction of 2-deoxyglucose uptake in morphine-tolerant rats

AU - Shibata, Shigenobu

AU - Tominaga, Keiko

AU - Watanabe, Shigenori

PY - 1995/6/12

Y1 - 1995/6/12

N2 - We examined the effects of μ-opioid receptor agonist and antagonists, and κ-opioid receptor agonist on the hypoxia/hypoglycemia-induced reduction in 2-deoxyglucose uptake of rat hippocampal slices. Naloxone, a μ-opioid receptor antagonist and (5,7,8)-(+)-3,4-dichloro-N-methyl-N-(7,8,1-pyrrolidinyl)-1-oxaspirol 4,5 dec-8-yl)-benzeneacetamide methanesulfonate, U-62,066E, a κ-opioid receptor agonist, showed neuroprotective actions against the hypoxia/hypoglycemia-induced deficit in glucose uptake. In contrast, morphine exhibited an exacerbating action. These results suggest that blockade of μ-opioid receptor-and stimulation of κ-opioid receptor-mediated functions has a protective role against the hypoxia/hypoglycemia-induced decreases in glucose metabolism in hippocampal slices. Chronic administration of morphine (10 mg/kg) for 9 days affected neither the basal nor the hypoxia/hypoglycemia-induced reduction in 2-deoxyglucose uptake. Rats treated with morphine chronically exhibited not only tolerance to the analgesic effect but also tolerance to the exacerbating action. However, chronic morphine did not modify U-62,066E-induced neuroprotection. These findings indicate that the receptor mechanisms of neuroprotection produced by the activation of κ-opioid receptors may not be involved in μ-opioid receptor function.

AB - We examined the effects of μ-opioid receptor agonist and antagonists, and κ-opioid receptor agonist on the hypoxia/hypoglycemia-induced reduction in 2-deoxyglucose uptake of rat hippocampal slices. Naloxone, a μ-opioid receptor antagonist and (5,7,8)-(+)-3,4-dichloro-N-methyl-N-(7,8,1-pyrrolidinyl)-1-oxaspirol 4,5 dec-8-yl)-benzeneacetamide methanesulfonate, U-62,066E, a κ-opioid receptor agonist, showed neuroprotective actions against the hypoxia/hypoglycemia-induced deficit in glucose uptake. In contrast, morphine exhibited an exacerbating action. These results suggest that blockade of μ-opioid receptor-and stimulation of κ-opioid receptor-mediated functions has a protective role against the hypoxia/hypoglycemia-induced decreases in glucose metabolism in hippocampal slices. Chronic administration of morphine (10 mg/kg) for 9 days affected neither the basal nor the hypoxia/hypoglycemia-induced reduction in 2-deoxyglucose uptake. Rats treated with morphine chronically exhibited not only tolerance to the analgesic effect but also tolerance to the exacerbating action. However, chronic morphine did not modify U-62,066E-induced neuroprotection. These findings indicate that the receptor mechanisms of neuroprotection produced by the activation of κ-opioid receptors may not be involved in μ-opioid receptor function.

KW - 2-Deoxyglucose

KW - Hippocampal slice

KW - Ischemia

KW - Morphine

KW - Tolerance

KW - κ-Opioid receptor

UR - http://www.scopus.com/inward/record.url?scp=0028978565&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028978565&partnerID=8YFLogxK

U2 - 10.1016/0014-2999(95)00152-B

DO - 10.1016/0014-2999(95)00152-B

M3 - Article

C2 - 7556401

AN - SCOPUS:0028978565

VL - 279

SP - 197

EP - 202

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 2-3

ER -